SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Physicians Realty Trust, et al. – ‘10-K’ for 12/31/16 – ‘EX-31.4’

On:  Friday, 2/24/17, at 9:51am ET   ·   For:  12/31/16   ·   Accession #:  1574540-17-7   ·   File #s:  1-36007, 333-205034-01

Previous ‘10-K’:  ‘10-K’ on 2/29/16 for 12/31/15   ·   Next:  ‘10-K’ on 3/1/18 for 12/31/17   ·   Latest:  ‘10-K’ on 2/22/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/24/17  Physicians Realty Trust           10-K       12/31/16  112:31M
          Physicians Realty L.P.

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.88M 
 2: EX-10.9     Material Contract                                   HTML    102K 
 5: EX-21.1     Subsidiaries List                                   HTML     77K 
 6: EX-23.1     Consent of Experts or Counsel                       HTML     30K 
 7: EX-23.2     Consent of Experts or Counsel                       HTML     30K 
 3: EX-12.1     Statement re: Computation of Ratios                 HTML     46K 
 4: EX-12.2     Statement re: Computation of Ratios                 HTML     47K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
10: EX-31.3     Certification -- §302 - SOA'02                      HTML     36K 
11: EX-31.4     Certification -- §302 - SOA'02                      HTML     36K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
13: EX-32.2     Certification -- §906 - SOA'02                      HTML     33K 
20: R1          Document and Entity Information                     HTML     63K 
21: R2          Consolidated Balance Sheets                         HTML    174K 
22: R3          Consolidated Balance Sheets (Parenthetical)         HTML     54K 
23: R4          Consolidated Statements of Operations               HTML    201K 
24: R5          Consolidated Statements of Comprehensive Income     HTML     60K 
                Statement                                                        
25: R6          Consolidated and Combined Statement of Equity       HTML    106K 
26: R7          Consolidated Statements of Changes in Capital       HTML    136K 
27: R8          Consolidated Statements of Cash Flows               HTML    263K 
28: R9          Organization and Business                           HTML     85K 
29: R10         Summary of Significant Accounting Policies          HTML    145K 
30: R11         Acquisitions and Dispositions                       HTML    509K 
31: R12         Intangibles                                         HTML    112K 
32: R13         Other Assets                                        HTML     46K 
33: R14         Debt                                                HTML     99K 
34: R15         Derivatives                                         HTML     48K 
35: R16         Accrued Expenses and Other Liabilities              HTML     47K 
36: R17         Stock-based Compensation                            HTML    107K 
37: R18         Fair Value Measurements                             HTML     69K 
38: R19         Tenant Operating Leases                             HTML     39K 
39: R20         Rent Expense                                        HTML     42K 
40: R21         Credit Concentration                                HTML     62K 
41: R22         Earnings Per Share and Earnings Per Unit            HTML    107K 
42: R23         Subsequent Events                                   HTML     46K 
43: R24         Quarterly Data                                      HTML    167K 
44: R25         Schedule Iii - Real Estate and Accumulated          HTML   1.87M 
                Depreciation                                                     
45: R26         Summary of Significant Accounting Policies -        HTML    189K 
                (Policies)                                                       
46: R27         Organization and Business - (Tables)                HTML     72K 
47: R28         Summary of Significant Accounting Policies -        HTML     80K 
                (Tables)                                                         
48: R29         Acquisitions and Dispositions - (Tables)            HTML    509K 
49: R30         Intangibles - (Tables)                              HTML    113K 
50: R31         Other Assets - (Tables)                             HTML     46K 
51: R32         Debt - (Tables)                                     HTML     87K 
52: R33         Derivatives - (Tables)                              HTML     37K 
53: R34         Accrued Expenses and Other Liabilities - (Tables)   HTML     47K 
54: R35         Stock-based Compensation - (Tables)                 HTML     92K 
55: R36         Fair Value Measurements - (Tables)                  HTML     64K 
56: R37         Tenant Operating Leases - (Tables)                  HTML     37K 
57: R38         Rent Expense - (Tables)                             HTML     37K 
58: R39         Credit Concentration - (Tables)                     HTML     64K 
59: R40         Earnings Per Share and Earnings Per Unit -          HTML    105K 
                (Tables)                                                         
60: R41         Subsequent Events - (Tables)                        HTML     44K 
61: R42         Quarterly Data - (Tables)                           HTML    162K 
62: R43         Organization and Business - (Details)               HTML     78K 
63: R44         Organization and Business - Schedule of Issuance    HTML     55K 
                and Sale of Common Stock (Details)                               
64: R45         Summary of Significant Accounting Policies -        HTML     31K 
                Principals of Consolidation (Details)                            
65: R46         Summary of Significant Accounting Policies -        HTML    100K 
                Noncontrolling Interests (Details)                               
66: R47         Summary of Significant Accounting Policies -        HTML     45K 
                Dividends and Distributions (Details)                            
67: R48         Summary of Significant Accounting Policies - Tax    HTML     38K 
                Status of Dividends and Distributions (Details)                  
68: R49         Summary of Significant Accounting Policies -        HTML     32K 
                Impairment of Intangible and Long-Lived Assets                   
                (Details)                                                        
69: R50         Summary of Significant Accounting Policies -        HTML     42K 
                Investments in Unconsolidated Entities (Details)                 
70: R51         Summary of Significant Accounting Policies - Real   HTML     37K 
                Estate Loans Receivable (Details)                                
71: R52         Summary of Significant Accounting Policies -        HTML     31K 
                Escrow Revenue (Details)                                         
72: R53         Summary of Significant Accounting Policies -        HTML     31K 
                Derivative Instruments (Details)                                 
73: R54         Summary of Significant Accounting Policies -        HTML     31K 
                Tenant Receivables, Net (Details)                                
74: R55         Summary of Significant Accounting Policies -        HTML     31K 
                Rental Revenue (Details)                                         
75: R56         Summary of Significant Accounting Policies - New    HTML     32K 
                Accounting Pronouncements (Details)                              
76: R57         Acquisitions and Dispositions - (Details)           HTML     62K 
77: R58         Acquisitions and Dispositions - 2016 Acquisitions   HTML   1.14M 
                (Details)                                                        
78: R59         2015 Acquisitions (Details)                         HTML    799K 
79: R60         Acquisitions and Dispositions - Assets Acquired     HTML     74K 
                and Liabilities Assumed (Details)                                
80: R61         Acquisitions and Dispositions - Pro Forma           HTML     76K 
                Information (Details)                                            
81: R62         Intangibles - (Details)                             HTML     50K 
82: R63         Intangibles - Carrying Amount of Intangible Assets  HTML     64K 
                and Liabilities (Details)                                        
83: R64         Intangibles - Acquired Lease Intangible             HTML     51K 
                Amortization (Details)                                           
84: R65         Intangibles - Amortization of Acquired Lease        HTML     56K 
                Intangibles (Details)                                            
85: R66         Other Assets - Additional Information (Details)     HTML     53K 
86: R67         Debt - (Details)                                    HTML    117K 
87: R68         Debt - Summary of Debt (Details)                    HTML     91K 
88: R69         Debt - Investment Grade Rating Schedule (Details)   HTML     65K 
89: R70         Debt - Principal Payments Due on Debt (Details)     HTML     49K 
90: R71         Derivatives - (Details)                             HTML     37K 
91: R72         Derivatives - Fair Value Interest Rate Swaps        HTML     54K 
                (Details)                                                        
92: R73         Accrued Expenses and Other Liabilities - (Details)  HTML     55K 
93: R74         Stock-based Compensation - (Details)                HTML     95K 
94: R75         Stock-based Compensation - Summary of Non-Vested    HTML     57K 
                Restricted Common Shares (Details)                               
95: R76         Stock-based Compensation - Weighted Average Grant   HTML     46K 
                Date Fair Value Assumptions (Details)                            
96: R77         Stock-based Compensation - Trust Restricted Share   HTML     58K 
                Activity (Details)                                               
97: R78         Fair Value Measurements - (Details)                 HTML     41K 
98: R79         Fair Value Measurements - Fair Value Financial      HTML     66K 
                Instruments (Details)                                            
99: R80         Tenant Operating Leases - (Details)                 HTML     44K 
100: R81         Rent Expense - (Details)                            HTML     40K  
101: R82         Rent Expense - Schedule of Minimum Lease            HTML     58K  
                Obligations (Details)                                            
102: R83         Credit Concentration - (Details)                    HTML     38K  
103: R84         Credit Concentration - Top Five Tenant Credit       HTML     50K  
                Concentrations (Details)                                         
104: R85         Credit Concentration - Top Five Geographic          HTML     50K  
                Concentrations (Details)                                         
105: R86         Earnings Per Share and Earnings Per Unit -          HTML    150K  
                Additional Information (Details)                                 
106: R87         Subsequent Events - Additional Information          HTML     79K  
                (Details)                                                        
107: R88         Quarterly Data - Additional Information (Details)   HTML     97K  
108: R89         Schedule Iii - Real Estate and Accumulated          HTML   1.58M  
                Depreciation (Details)                                           
109: R90         Schedule Iii - Real Estate and Accumulated          HTML     60K  
                Depreciation (Details 2)                                         
111: XML         IDEA XML File -- Filing Summary                      XML    188K  
110: EXCEL       IDEA Workbook of Financial Reports                  XLSX    202K  
14: EX-101.INS  XBRL Instance -- doc-20161231                        XML  10.67M 
16: EX-101.CAL  XBRL Calculations -- doc-20161231_cal                XML    341K 
17: EX-101.DEF  XBRL Definitions -- doc-20161231_def                 XML   1.76M 
18: EX-101.LAB  XBRL Labels -- doc-20161231_lab                      XML   3.32M 
19: EX-101.PRE  XBRL Presentations -- doc-20161231_pre               XML   2.08M 
15: EX-101.SCH  XBRL Schema -- doc-20161231                          XSD    432K 
112: ZIP         XBRL Zipped Folder -- 0001574540-17-000007-xbrl      Zip    661K  


‘EX-31.4’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 31.4


Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jeffrey N. Theiler, certify that:
1.
I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2016, of Physicians Realty L.P.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
 
Executive Vice President and Chief Financial Officer of Physicians Realty Trust, the general partner of the registrant





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/24/1710-K,  8-K,  S-3ASR
For Period end:12/31/16
 List all Filings 
Top
Filing Submission 0001574540-17-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 3:37:39.1am ET